Many biopsies may soon be avoidable with the advent of an accurate biosensor for prostate cancer that detects biomarkers in the blood.
![When diagnosing prostate cancer, two biomarkers are better than one](https://www.advancedsciencenews.com/wp-content/uploads/2023/12/national-cancer-institute-E9Ucfek-Lp0-unsplash.jpg)
Many biopsies may soon be avoidable with the advent of an accurate biosensor for prostate cancer that detects biomarkers in the blood.
Research uncovers how tumor cells’ stem cell-like qualities and their ability to evade the immune system helps some cancers spread during metastasis.
How manipulating electron flow through cells’ mitochondria could help enhance immunotherapy.
A new approach to cancer treatment combines gene editing with a known chemotherapy drug, harnessing the benefits of both for better outcomes.
Scientists are hopeful that a new, more sensitive test for detecting ovarian cancer might provide better options, especially for patients with BRCA genes.
A specific epigenetic signature in patients who respond to chemotherapy offers potential to improve treatment.
Bacteria residing inside tumors provide a surprisingly powerful immunotherapy platform to combat different cancers.
Inspired by brain-invading bacteria, researchers have created nanocapsules that covertly shuttle drugs across the blood–brain barrier.
A new hydrogel platform helps monitor chemotherapies in the body in real-time, allowing their side effects and potency to be better understood.
This nanoparticle cancer therapy hijacks biological processes to target cancer cells and destroy them with self-assembling components.